Transplantation Market Size, Share & Trends Report

Transplantation Market Size, Share & Trends Analysis Report By Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), By Application (Organ, Tissue Transplant), By End Use, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-1-68038-864-0
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Research Methodology

A three-pronged approach was followed for deducing the transplantation market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:

Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for transplantation market to gather the most reliable and current information possible.

  • We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
  • We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
  • We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
  • We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
  • We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.

Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of transplantation market data depending on the type of information we’re trying to uncover in our research.

  • Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.

  • Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.

  • Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.

  • Qualitative Functional Deployment (QFD) Modelling for market share assessment.

Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.

  • Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.

  • Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.

  • This step also entails the finalization of the report scope and data representation pattern.

  • Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.

Transplantation Market Categorization:

The transplantation market was categorized into four segments, namely product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), application (Organ Transplantation, Tissue Transplantation), end-use (Hospitals, Transplant Centers), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa).

Segment Market Methodology:

The transplantation market was segmented into product, application, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:

Market research approaches: Bottom-up

  • Demand estimation of each product across countries/regions summed up to from the total market.

  • Variable analysis for demand forecast.

  • Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.

  • Primary interviews for data revalidation and insight collection.

Market research approaches: Top-down

  • Used extensively for new product forecasting or analyzing penetration levels.

  • Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.

  • Primary interviews and vendor-based primary research for variable impact analysis.

Market research approaches: Combined

  • This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.

Regional Market Methodology:

The transplantation market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; the UK; Germany; France; Italy; Spain; Denmark; Norway; Sweden; China; Japan; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait.

All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.

Transplantation market companies & financials:

The transplantation market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:

  • Stryker Corporation -Stryker Corporation offers product and services related to medical, surgical, orthopedics, & neurotechnology verticals. The product offerings include joint replacement solutions; micro & spinal implant systems; endoscopic products; powered surgical instruments; orthobiologics; trauma-related products; patient handling equipment; surgical navigation systems; and emergency equipment. Stryker Osteosynthesis is the subsidiary of Stryker Corporation, which is operational in craniomaxillofacial and trauma products. The company operates in over 100 countries.

  • Zimmer Biomet - Zimmer Biomet designs, manufactures, and markets orthopedic products, sport medicines, trauma & extremities products, dental implants, thoracic & craniomaxillofacial products, and related surgical products. The company operates through three geographic operating segments-Americas, EMEA, & Asia Pacific-and four product category segments-spine, office-based technology, craniomaxillofacial & thoracic, and dental.

  • Medtronic - Medtronic is one of the world’s largest medical technology and healthcare solutions company that manufactures medical devices. The company applies biomedical engineering in research, design, manufacture, and sale of products for alleviating pain, restoring health, & extending life. The company serves patients, clinicians, physicians, and hospitals in over 160 countries. It operates under cardiovascular group, restorative therapies group, and diabetes group. The company has more than 53,000 patents. It operates from 260 locations. The company has charitable contribution of USD 80 billion. Medtronic, Inc. operates as a subsidiary of Medtronic plc.

  • AbbVie, Inc - AbbVie, Inc is a pharmaceutical company manufactures and markets biopharmaceuticals & small molecule drugs. The company operates through various segments, including immunology, oncology, neuroscience, virology, and general medicine. It currently operates in over 170 countries and has 21 primary research & manufacturing facilities worldwide.

  • Arthrex, Inc. - Arthrex, Inc. is a medical device company that manufactures and markets orthopedic products. The company offers products in various categories, including shoulder, knee, elbow, hand and foot, wrist & ankle, hip, orthobiologics, and imaging & resection. The company operates across various locations globally and has offices in Germany, Brazil, Belgium, Japan, Austria, China, Switzerland, France, Poland, and UAE.

  • Novartis - Novartis manufactures and develops healthcare products through three key segments: innovative medicines, Alcon, & Sandoz. The company offers products in various categories: innovative medicines, generics & biosimilars, and eye care devices. The company has a vast geographical presence in more than 180 countries and has a wide distribution network. The company has research locations in Switzerland, the U.S., China, Singapore, India, and Japan, among others.

  • 21st Century Medicine - 21st Century Medicine is a research company that is engaged in the development of perfusates and cryopreservation methods for the preservation of human organs, tissues, & cells at cryogenic temperatures. The company operates through various segments: biopharmaceuticals, assisted reproductive technology, transplantation, and other potential applications.

  • BioLife Solutions - BioLife Solutions is engaged in the biopreservation of media products for cells, tissues, and organs. The company also serves as a contract research organization providing consultation and customization processes. It operates through a well-established distribution system and has a well-defined cold chain management for products.

  • Teva Pharmaceutical Industries Ltd. - Teva Pharmaceutical Industries Ltd. develops, manufactures, and markets specialty & generic medicines internationally. The specialty segment offers specialty medicines for use in respiratory and central nervous system indications, oncology, women’s health, and others. The generic segment offers high-potency drugs, narcotics, cytotoxic substances, and hormones in various dosage forms such as gels, creams, ointments, capsules, tablets, injectable, inhalants, & liquids. It also manufactures and sells APIs. The company has collaborative agreements with Regeneron Pharmaceuticals, Inc. and Procter & Gamble.

  • Veloxis Pharmaceuticals A/S - Veloxis Pharmaceuticals A/S is a Danish specialty pharmaceutical company (commercial stage) that is focused on improving the lives of transplant patients. The company has developed MeltDose-designed to increase the bioavailability & absorption of select orally administered drugs-and ENVARSUS XR-which is based on its unique & patented delivery technology. 

Value chain-based sizing & forecasting

Supply Side Estimates

  • Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.

  • Segment revenue determination via variable analysis and penetration modeling.

  • Competitive benchmarking to identify market leaders and their collective revenue shares.

  • Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.

Demand side estimates

  • Identifying parent markets and ancillary markets

  • Segment penetration analysis to obtain pertinent

  • revenue/volume

  • Heuristic forecasting with the help of subject matter experts

  • Forecasting via variable analysis

Transplantation Market Report Objectives:

  • Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.

  • Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.

  • Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.

Transplantation Market Report Assumptions:

  • The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.

  • The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.

  • We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.

  • All market estimates and forecasts have been validated through primary interviews with the key industry participants.

  • Inflation has not been accounted for to estimate and forecast the market.

  • Numbers may not add up due to rounding off.

  • Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).

  • Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).

  • Latin America includes Central American countries and the South American continent

  • Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.

Primary Research

GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.

We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:

  • Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.

  • Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.

The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.

What questions do you have? Get quick response from our industry experts. Request a Free Consultation



This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.



We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon